NCT01899066 Efficacy Study of Lucentis in the Treatment of Retinoblastoma Status UNKNOWN Phase PHASE2
NCT01872819 Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay Status COMPLETED Phase NA
NCT01843647 Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients Status UNKNOWN Phase PHASE2
NCT01829178 Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma Status COMPLETED Phase PHASE2/PHASE3
NCT01807091 Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome Status COMPLETED Phase NA
NCT01783054 Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas Status TERMINATED Phase EARLY_PHASE1
NCT01780181 Clinical Study of Chemotherapy Combined With Chinese Medicine on Survival Affect of Elderly Patients With Lung Cancer Status COMPLETED Phase N/A
NCT01719536 Icotinib Versus First-line Chemotherapy Plus Maintenance Treatment in EGFR Positive Lung Adenocarcinoma Patients Status COMPLETED Phase PHASE3
NCT01712347 An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer Status COMPLETED Phase N/A
NCT01709162 Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma Status TERMINATED Phase PHASE2
NCT01707329 Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment Status UNKNOWN Phase PHASE2
NCT01696695 An Observational Study of First-Line Capecitabine Based Chemotherapy in Participants With Metastatic Colorectal Cancer Status COMPLETED Phase N/A
NCT01696669 Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults Status COMPLETED Phase PHASE2
NCT01665417 Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma Status UNKNOWN Phase PHASE4
NCT01648517 Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy Status COMPLETED Phase PHASE2
NCT01616238 A Study for Older Adults With Acute Lymphoblastic Leukaemia Status COMPLETED Phase PHASE2
NCT01576692 Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma Status COMPLETED Phase PHASE1